Pacific Biosciences of California, Inc. (PACB)
1.32
-0.08
(-5.71%)
USD |
NASDAQ |
Mar 20, 16:00
1.33
+0.01
(+0.76%)
After-Hours: 18:26
Pacific Biosciences of California Cash from Financing (Quarterly) : 0.00 for Dec. 31, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 1.886M |
| Twist Bioscience Corp. | 0.298M |
| Boston Scientific Corp. | -184.00M |
| Intellia Therapeutics, Inc. | 1.977M |
| Enovis Corp. | -72.92M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -19.07M |
| Cash from Investing (Quarterly) | 26.03M |
| Free Cash Flow | -118.92M |
| Free Cash Flow Per Share (Quarterly) | -0.066 |
| Free Cash Flow to Equity (Quarterly) | -22.27M |
| Free Cash Flow to Firm (Quarterly) | -18.18M |
| Free Cash Flow Yield | -30.04% |